Literature DB >> 15346844

Depletion of antioxidants is associated with no-reflow phenomenon in acute myocardial infarction.

Hidenari Matsumoto1, Nobutaka Inoue, Hideyuki Takaoka, Katsuya Hata, Toshiro Shinke, Ryohei Yoshikawa, Hiroyuki Masai, Satoshi Watanabe, Toru Ozawa, Mitsuhiro Yokoyama.   

Abstract

BACKGROUND: No-reflow phenomenon is observed in approximately one-third of patients after percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI), and is associated with poor functional and clinical outcomes. On the other hand, the formation of free radicals in vasculature exerts deleterious effects on coronary microcirculation. HYPOTHESIS: We hypothesized that redox state in coronary circulation may play a crucial role in no-reflow phenomenon in AMI.
METHODS: Consecutive 26 patients with first AMI who underwent primary PCI < 24 h after onset were enrolled. Before PCI, blood samples were obtained from coronary sinus to measure plasma or serum antioxidative vitamins (vitamin C, vitamin E, and beta-carotene) and antioxidative enzymes (extracellular glutathione peroxidase [GPX], superoxide dismutase, and catalase). After PCI, the corrected Thrombolysis In Myocardial Infarction (TIMI) frame count (CTFC) was measured in the target vessel. Patients with TIMI < or = 2 flow despite an optimal PCI result were designated as no-reflow group (Group NR, n = 6) and the others as reflow group (Group R, n = 20).
RESULTS: Levels of vitamin C, vitamin E, and GPX before PCI were significantly lower in Group NR than in Group R. The CTFC correlated inversely with levels of vitamin C, vitamin E, and GPX (p < 0.05).
CONCLUSIONS: Depletion of antioxidants is associated with no-reflow phenomenon in AMI. These findings strongly suggest that the redox state in coronary circulation plays an important role in the pathogenesis of no-reflow phenomenon.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15346844      PMCID: PMC6654431          DOI: 10.1002/clc.4960270809

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  5 in total

Review 1.  Smart MR imaging agents relevant to potential neurologic applications.

Authors:  C S Bonnet; E Tóth
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-15       Impact factor: 3.825

2.  Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: A randomized factorial trial.

Authors:  Chunhong Chen; Xianghua Fu; Wei Li; Xinwei Jia; Shiru Bai; Wei Geng; Kun Xing
Journal:  Exp Ther Med       Date:  2015-07-07       Impact factor: 2.447

3.  Amelioration of persistent left ventricular function impairment through increased plasma ascorbate levels following myocardial infarction.

Authors:  Nicolás Valls; Juan G Gormaz; Rubén Aguayo; Jaime González; Roberto Brito; Daniel Hasson; Matías Libuy; Cristóbal Ramos; Rodrigo Carrasco; Juan C Prieto; Gastón Dussaillant; Ángel Puentes; Viviana Noriega; Ramón Rodrigo
Journal:  Redox Rep       Date:  2016-02-24       Impact factor: 4.412

4.  Redox-sensitive contrast agents for MRI based on reversible binding of thiols to serum albumin.

Authors:  Natarajan Raghunand; Bhumasamudram Jagadish; Theodore P Trouard; Jean-Philippe Galons; Robert J Gillies; Eugene A Mash
Journal:  Magn Reson Med       Date:  2006-06       Impact factor: 4.668

Review 5.  Myocardial reperfusion injury and oxidative stress: Therapeutic opportunities.

Authors:  Jaime González-Montero; Roberto Brito; Abraham Ij Gajardo; Ramón Rodrigo
Journal:  World J Cardiol       Date:  2018-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.